NGK SPARK PLUG has announced the beginning of a strategic partnership with neoplas med GmbH, a German medical company that specialises in innovative cold plasma jet technology which helps in the treatment of wounds.

The collaboration will involve the world’s leading ignition and vehicle electronics specialist investing growth capital from its Venture Capital Fund CVC (jointly operated with Pegasus Tech Ventures) into this future-oriented medical company. The move further demonstrates NGK SPARK PLUG’s commitment to promoting the creation of new businesses. 

As set out in NGK SPARK PLUG’s 2030 Long-Term Management Plan ‘NITTOKU BX’, the company is currently transforming its business portfolio to increase its activities in non-internal combustion engine-related areas. This has resulted in the focus on creating new businesses in the fields of ‘Smart Health’, ‘Smart Mobility’ and ‘Utility’. 

NGK has had a decades-long involvement in the medical sector, where it has placed a particular emphasis on the areas: early disease detection, respiratory care and wound care.

Dirk Schapeler, President of Business Creation at NGK SPARK PLUG, said: “With our investment, we want to accompany the collaboration with neoplas med in the field of state-of-the-art wound healing technologies to improve the quality of life of patients worldwide.”

Damien Germès, President & CEO of NGK SPARK PLUG EUROPE GmbH, Regional President EMEA and Corporate Officer of the Global Headquarters in Japan, said: “This strategic partnership with German neoplas med offers a snapshot of the transformation currently occurring at our company. Next to ‘Smart Mobility’ and ‘Utility’, ‘Smart Health’ is another one of the areas we are investing in as we continue on our mission to become an environmentally sustainable company that brings new value to the world.”